JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
MARFX
Price
$24.22
Change
-$0.09 (-0.37%)
Updated
Sep 20 closing price
Ad is loading...

JVMTX vs MARFX

Header iconJVMTX vs MARFX Comparison
Open Charts JVMTX vs MARFXBanner chart's image
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
BlackRock Mid-Cap Value Institutional
Price$24.22
Change-$0.09 (-0.37%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JVMTX vs MARFX Comparison Chart
Loading...
VS
JVMTX vs. MARFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMTX is a Buy and MARFX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. MARFX (1.07B). MARFX pays higher dividends than JVMTX: MARFX (1.55) vs JVMTX (0.73). JVMTX was incepted earlier than MARFX: JVMTX (11 years) vs MARFX (30 years). MARFX is a more actively managed with annual turnover of: 91.00 vs. JVMTX (41.00). JVMTX has a lower initial minimum investment than MARFX: JVMTX (0) vs MARFX (2000000). JVMTX annual gain was more profitable for investors over the last year : 19.27 vs. MARFX (16.21). JVMTX return over 5 years is better than : 43.64 vs. MARFX (39.88).
JVMTXMARFXJVMTX / MARFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years30 years-
Gain YTD11.0108.449130%
Front LoadN/AN/A-
Min. Initial Investment02000000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.4B1.07B2,185%
Annual Yield % from dividends0.731.5547%
Returns for 1 year19.2716.21119%
Returns for 3 years13.3811.91112%
Returns for 5 years43.6439.88109%
Returns for 10 years63.3411.36558%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems